| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
collagen type I alpha 1 chain | 0.430 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
family with sequence similarity 234 member A | 1.000 | 0.077 | 1.5E-12 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2019 | 2019 | ||||||||
|
PDZ domain containing ring finger 4 | 0.805 | 0.269 | 9.1E-07 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
hemoglobin subunit beta | 0.494 | 0.808 | 1.2E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
tubulin tyrosine ligase like 11 | 0.931 | 0.077 | 6.2E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
activating transcription factor 3 | 0.494 | 0.885 | 8.9E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
ankyrin repeat domain 26 | 0.711 | 0.308 | 3.6E-24 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
Rho family GTPase 3 | 0.656 | 0.385 | 0.97 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
otoraplin | 0.805 | 0.154 | 4.9E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
potassium channel tetramerization domain containing 20 | 0.861 | 0.192 | 9.4E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
regulator of G protein signaling 12 | 0.769 | 0.462 | 4.1E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
glutathione S-transferase alpha 11, pseudogene |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | |||||||||||
|
receptor accessory protein 3 | 0.792 | 0.308 | 1.5E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
zinc finger SWIM-type containing 6 | 0.626 | 0.577 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
fatty acid binding protein 6 | 0.743 | 0.346 | 1.6E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
psoriasis susceptibility 1 candidate 1 | 0.656 | 0.731 | 2.7E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
cytochrome P450 family 3 subfamily A member 5 | 0.511 | 0.846 | 6.3E-17 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
transcriptional repressor GATA binding 1 | 0.537 | 0.769 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
poly(ADP-ribose) polymerase 1 | 0.389 | 0.923 | 3.3E-04 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
RE1 silencing transcription factor | 0.535 | 0.808 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
RNA binding motif single stranded interacting protein 2 | 0.890 | 0.154 | 1.4E-06 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
MAX interactor 1, dimerization protein | 0.547 | 0.615 | 1.1E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
platelet endothelial aggregation receptor 1 | 0.722 | 0.346 | 3.5E-20 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
ATPase H+/K+ transporting subunit alpha | 0.575 | 0.769 | 9.4E-12 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
intracisternal A particle-promoted polypeptide | 0.760 | 0.308 | 2.1E-05 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 |